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in Atherosclerosis
Which Is the Chicken, and Which Is the Egg?*Takehiro Nakahara, MD, Jagat Narula, MD, PHD, H. William Strauss, MDI n this issue of the Journal, Joshi et al. (1) ask thequestion, “Does vascular calciﬁcation accelerateinﬂammation?” To answer this question, the au-
thors performed a substudy using data from the dal-
PLAQUE trial (1), which was a phase 2 randomized
trial to determine the vascular effects of the choles-
terol ester transfer protein inhibitor dalcetrapib. As
part of the trial, the investigators measured calciﬁca-
tion and vascular inﬂammation. Calciﬁcation was
measured in the ascending aorta, aortic arch, and ca-
rotid and coronary arteries on computed tomography
(CT), with an attenuation threshold of 130 HU in 3
contiguous voxels on consecutive transaxial slices
along the length of the arterial segment. The extent
of calciﬁcation was expressed both in Agatston units
and as a volume in cubic millimeters. Baseline and
follow-up studies were compared to ensure that the
same length of artery was analyzed on both scans.SEE PAGE 69Vascular inﬂammation was measured with ﬂuoro-
deoxyglucose (FDG) positron emission tomography
(PET)-CT imaging in the aorta and carotid arteries.
Arterial FDG uptake was quantiﬁed by delineating a
region of interest on coregistered transaxial PET/CT
images. The maximum arterial standardized uptake
value (SUV) was determined in the aorta and carotid
arteries from the ratio of SUV of the artery compared*Editorials published in the Journal of the American College of Cardiology
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paper.with background venous activity. They enrolled 130
patients with a median age of 65 years, 82% male,
with previous known coronary heart disease or at
high risk (diabetes or >20% risk by Framingham
risk scoring). Two measurements of calciﬁcation
(CT) and arterial inﬂammation (FDG-PET/CT) were
performed—the ﬁrst at the time of entry and the
second 6 months later.
The investigators report 4 major observations on
the basis of their analysis: 1) an association of age >65
years with higher baseline calcium scores; 2) a
decrease in FDG uptake (inﬂammation) in the carotid
arteries if carotid calcium was absent at baseline; 3)
no change in carotid inﬂammation if calciﬁcation was
present in the carotid arteries at baseline; and 4) no
effect of the cholesteryl ester transfer protein inhib-
itor dalcetrapib.
The question raised by the authors is important. It
is generally accepted that atheroma is initiated by
lipoprotein cholesterol complexes trapped beneath
the endothelium. The trapped lipoprotein causes an
inﬂammatory response, resulting in the recruitment
of phagocytic cells to the lesion. Depending on
the amount of lipid and the effectiveness of the
phagocytic cells, the lesion may resolve or progress.
Progressive lesions develop a necrotic core with ab-
undant macrophages, foam cells, cellular debris (from
inefﬁcient efferocytosis), and extravasation of eryth-
rocytes from newly formed fragile capillaries (2).
Lesions with an intense inﬂammatory response often
have microcalciﬁcations (3), likely due to a combina-
tion of necrotic cell debris serving as a nidus for
calciﬁcation and a loss of calciﬁcation inhibitory fac-
tors (4,5). Although microcalciﬁcation of the lesions
predisposes to plaque rupture, coalescence of calci-
ﬁcation may result in sheets of calcium, effectively
separating the residual inﬂammatory site from the
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80vascular lumen, making the lesion less likely to
rupture.
Studies of vascular calciﬁcation and vascular
inﬂammation (6,7) suggest that there is little overlap
between vascular calciﬁcation seen on clinical CT and
sites of vascular FDG uptake on FDG-PET/CT. Over
short intervals, vascular inﬂammation, as measured
on serial FDG-PET/CT studies, is stable (8), but on
longer intervals, vascular FDG uptake often waxes
and wanes (6). Meirelles et al. (6) found a change in
vascular FDG uptake in 55% of patients between the
baseline scan and rescan at a mean of 7 months. On
the other hand, calciﬁcation tends to be stable or in-
crease over time (6).
There is increasing recognition of the role of micro-
calciﬁcation early in the evolution of inﬂamed
atheroma, but these microcalciﬁcations are only
visible at histopathology (9) or with high-resolution CT
(3) of vascular specimens (e.g., carotid endarterectomy
specimens). Recently, PET imaging with ionic F-18
ﬂuoride has beenproposed as themost sensitivemarker
of the active process of plaque calciﬁcation. However,
dense vascular calciﬁcation as visible on clinical CT is
often associated with plaque stabilization (10).
Abdelbaky et al. (11) evaluated 137 patients with
serial FDG-PET/CT scans for locations that had FDG
uptake at baseline without calciﬁcation (inﬂamma-
tion only) and that developed calciﬁcation on the
follow-up scan. New vascular calciﬁcation developedin 9% of segments (with the highest SUV at baseline),
suggesting that inﬂammation preceded calciﬁcation;
these investigators also observed that the segments
with stable calcium at baseline and follow-up scans
had the lowest SUV.
If we accept the observations that: 1) vascular
inﬂammation precedes calciﬁcation; 2) vascular
inﬂammation waxes and wanes; 3) vascular calciﬁ-
cation is stable or increases; and 4) vascular inﬂam-
mation and calciﬁcation rarely co-localize, then it is
also possible that new inﬂammation might appear at
the pre-existing sites of calciﬁcation. Histopatholog-
ical data (3,9) suggest that some lesions remain
inﬂamed, even in the presence of calcium, particu-
larly if the calciﬁcation is not very dense. In light of
the pathophysiology of atheroma, it is less likely that
calciﬁcation causes inﬂammation and more likely that
new inﬂammation could occur at sites of calciﬁed
atheroma. It is unlikely that the chicken or egg
dilemma can be answered by the serial PET/CT
studies of atheroma; it may need more experimental
data and a revisiting of the basic science of
calciﬁcation.
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